Guidelinevery high evidence
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
Circulation·June 9, 2026·PMID 42263147
Why it mattersThis statement provides a unified framework for cardiologists and internists to move beyond single-disease risk assessment, addressing the clustering of cardiovascular, kidney, and metabolic risks. It operationalizes how to use the latest risk equations to personalize preventive therapy decisions and improve population-level outcomes.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled